
Opinion|Videos|September 6, 2024
Evaluating Efficacy Between Intravenous and Subcutaneous Biologics
Author(s)Jennifer Seminerio, MD
An expert clinician expands on efficacy results seen in a study comparing intravenous and subcutaneous biologics.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- IV vs. subQ efficacy has been studied in patients with ulcerative colitis. What did those results demonstrate, and do they impact your clinical practice?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Lipfendra, first oral PCSK9 inhibitor
2
How the most favored nation drug pricing policy is quietly reshaping drug development and clinical research
3
Capital Rx is now Judi Rx in a company rebrand
4
FTC secures settlement with Caremark, locks in up to $8.5 billion in consumer savings
5

























